MasterCard (NYSE:MA): Buckingham has raised its estimates on MasterCard, a decision largely attributed to slightly faster than expected U.S. volume growth and favorable business trends. The shares are Buy rated, with a a $670 price target, raised from $630.
Celgene (NASDAQ:CELG): RW Baird recommends continued purchasing of Celgene stock, citing its new $3 billion share repurchase program and the publication of new trial data for apremilast’s PALACE-1 efficacy. It rates the shares at Outperform with a $130 price target.
L Brands (NYSE:LTD): RW Baird maintains that L Brands has an attractive risk/reward profile, and remains compelling citing international potential, expectations for margin expansion, and consistent execution. Shares are Outperform rated with a $58 price target.
Dendreon (NASDAQ:DNDN): Since use trends for Dendreon’ Provenge have been stuck in neutral with competition blocking its growth, RW Baird recommends that investors stay on the sidelines for now, despite management’s confidence that Provenge can bounce back near term. Shares are Neutral-rated, and the price target has been lowered to $5 from $6.
Don’t Miss: 5 Simple Ways to Control Your Credit Card Debt.